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Abstract
The transforming growth factor b (TGFb) superfamily proteins are principle regulators of numerous biological functions.
Although recent studies have gained tremendous insights into this growth factor family in female reproduction, the
functions of the receptors in vivo remain poorly defined. TGFb type 1 receptor (TGFBR1), also known as activin receptor-like
kinase 5, is the major type 1 receptor for TGFb ligands. Tgfbr1 null mice die embryonically, precluding functional
characterization of TGFBR1 postnatally. To study TGFBR1–mediated signaling in female reproduction, we generated a
mouse model with conditional knockout (cKO) of Tgfbr1 in the female reproductive tract using anti-Mu ¨llerian hormone
receptor type 2 promoter-driven Cre recombinase. We found that Tgfbr1 cKO females are sterile. However, unlike its role in
growth differentiation factor 9 (GDF9) signaling in vitro, TGFBR1 seems to be dispensable for GDF9 signaling in vivo.
Strikingly, we discovered that the Tgfbr1 cKO females develop oviductal diverticula, which impair embryo development and
transit of embryos to the uterus. Molecular analysis further demonstrated the dysregulation of several cell differentiation
and migration genes (e.g., Krt12, Ace2, and MyoR) that are potentially associated with female reproductive tract
development. Moreover, defective smooth muscle development was also revealed in the uteri of the Tgfbr1 cKO mice. Thus,
TGFBR1 is required for female reproductive tract integrity and function, and disruption of TGFBR1–mediated signaling leads
to catastrophic structural and functional consequences in the oviduct and uterus.
Citation: Li Q, Agno JE, Edson MA, Nagaraja AK, Nagashima T, et al. (2011) Transforming Growth Factor b Receptor Type 1 Is Essential for Female Reproductive
Tract Integrity and Function. PLoS Genet 7(10): e1002320. doi:10.1371/journal.pgen.1002320
Editor: Gregory S. Barsh, Stanford University School of Medicine, United States of America
Received May 10, 2011; Accepted August 9, 2011; Published October 20, 2011
Copyright:  2011 Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Serum progesterone analysis was performed at the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core,
supported by NICHD (SCCPRR) grant U54-HD28934. This research was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human
Development (NIH grant HD033438 to MMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mmatzuk@bcm.edu
¤ Current address: Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College
Station, Texas, United States of America
Introduction
The transforming growth factor b (TGFb) superfamily, the
largest family of secreted growth factors in mammals, is a
conserved family of proteins that play key roles in diverse
physiological and pathological processes [1–6]. The pathway
consists of ligands, receptors, and SMAD transducers, and is
tightly controlled by various regulatory layers such as ligand traps
(e.g., noggin, follistatin, and gremlin), inhibitory SMADs (i.e.,
SMAD6 and SMAD7), as well as multiple interactive pathways
that cross talk with TGFb signaling proteins in a context-specific
manner [7–9]. TGFb ligands bind to their type 2 and type 1
receptors and activate intracellular SMAD proteins including
receptor-regulated SMADs and common SMAD (SMAD4) to
initiate signal transduction. Although more than 40 TGFb family
members have been discovered to date, there are only seven type 1
receptors (ACVRL1, ACVR1, BMPR1A, ACVR1B, TGFBR1,
BMPR1B, ACVR1C) and five type 2 receptors (TGFBR2,
AMHR2, ACVR2, ACVR2B, and BMPR2) in mammals
[10,11]. The receptor-regulated SMADs can be divided into
TGFb/activin responsive SMADs (i.e., SMAD2/3) and bone
morphogenetic protein (BMP) responsive SMADs (i.e., SMAD1/
5/8) based on the ligands with which they are associated in the
signal transduction cascades [2,7].
Recent studies have revealed that the TGFb signaling pathway
is critically involved in multiple reproductive events including, but
not limited to, ovarian folliculogenesis [3,12–15], cumulus cell
expansion and ovulation [16–18], uterine decidualization [19],
and embryo implantation [20]. Disturbances in TGFb signaling
have been shown to lead to severe pathological conditions such as
cancer [1,2,4–6,21–26], making it an appealing candidate
pathway for therapeutic interventions. Early studies in our
laboratory demonstrated that inhibin a is a tumor suppressor
specific to the gonad and adrenal glands [21], highlighting the
functional importance of TGFb family proteins. Subsequent
studies demonstrated that the BMP signaling pathway serves as
PLoS Genetics | www.plosgenetics.org 1 October 2011 | Volume 7 | Issue 10 | e1002320a brake for ovarian tumor development [23,26]. During recent
years, significant progress has been made toward understanding
the roles of this growth factor family in female reproduction
[2,3,27–30]; however, the functions of the receptors in vivo remain
poorly defined, partially due to receptor redundancy [26,31–34] or
lethal phenotypes of genetically engineered ubiquitous null mouse
models.
TGFBR1 is the type 1 receptor for TGFb ligands [2]. In vitro,
TGFBR1 can also mediate the signaling of growth differentiation
factor 9 (GDF9) [35], an oocyte-secreted protein required for early
ovarian folliculogenesis, cumulus cell functions [12,36–41], and
oocyte developmental competence [42,43]. The above evidence
points to a possible role of TGFBR1 in female reproduction in vivo.
However, the functional significance of TGFBR1 in the female
reproductive tract is unknown because Tgfbr1 null mice die
embryonically [44].
Advances in gene targeting technology make it possible to
dissect gene functions in specific tissues using a conditional gene
inactivation (Cre-loxP) strategy [45]. Our laboratory has successfully
utilized this technique to expand the understanding of reproductive
functions of TGFb signaling components [18,23,26,46,47]. In the
current study, we generated a conditional knockout (cKO) of Tgfbr1
in the female reproductive tract using anti-Mu ¨llerian hormone
receptor type 2 (Amhr2)-Cre. We found that Tgfbr1 cKO mice are
sterile. Interestingly, instead of manifesting an overt ovarian
phenotype, these mice develop striking oviductal and uterine
phenotypes, thereby uncovering a novel role of TGFBR1–mediated
signaling in female reproductive tract development and function.
Results
Generation of Tgfbr1 Conditional Knockout Mice
Tgfbr1 null mice die embryonically [44], precluding functional
characterization of TGFBR1 postnatally. To study TGFBR1–
mediated signaling in female reproduction, we used a Tgfbr1
flox
allele and a Tgfbr1
bgal allele, in which a b-galactosidase (b-gal)
reporter was inserted into the Tgfbr1 locus to create a null allele
and to monitor spatiotemporal expression of Tgfbr1. To ensure
maximal deletion of the Tgfbr1 gene, the Tgfbr1
bgal null allele was
used in the breeding scheme to produce Tgfbr1 mutant mice. Mice
carrying these alleles were crossed with mice harboring the Amhr2-
Cre allele [48], which recombines floxed alleles in granulosa cells
[49] and Mu ¨llerian duct derived tissues (e.g., the smooth muscle
layers of the uterus and oviduct but not the epithelial com-
partment) [50–52] to produce Tgfbr1 cKO mice (Tgfbr1
flox/bgal;
Amhr2
cre/+) (Figure 1A). Recombination of the Tgfbr1
flox allele and
reduction of Tgfbr1 mRNA transcripts were confirmed in the
ovary, oviduct, and uterus (Figure 1B–1F).
Tgfbr1 cKO Mice Are Sterile and Develop Prominent
Oviductal Diverticula
Whereas control female mice (Tgfbr1
flox/bgal) lacking Amhr2
cre/+
demonstrated normal fertility and fecundity during a 6-month
breeding period (8.560.2 pups/litter and 1.160.0 litter/month),
the Tgfbr1 cKO female mice were sterile (Table 1). Copulatory
plugs were found in the Tgfbr1 cKO females, indicating the
infertility was not due to disrupted mating behavior. These results
suggest TGFBR1 is required for female fertility.
To examine the structural integrity of the reproductive tract and
determine possible causes of sterility in the Tgfbr1 cKO females, we
performed morphological and histological analyses of Tgfbr1 cKO
and control mice. Strikingly, we found the development of
bilateral oviductal diverticula (i.e., clear fluid-filled outpouchings
that are present throughout the length of each oviduct) in 100% of
the Tgfbr1 cKO females examined (Figure 2A–2D). This
phenotype highlights the importance of TGFBR1 in the oviduct
where its expression was detected in both smooth muscle and
epithelial compartments (Figure 2E). Deletion of Tgfbr1 was
expected only in the smooth muscle compartment due to the
presence of Amhr2-Cre activity in the mesenchymal cells that give
rise to the smooth muscle cells but not the epithelial cells. The
oviductal diverticula enlarged with age and were characterized by
a single layer of flattened epithelium and disrupted smooth muscle
layers, as demonstrated by b-gal staining (Figure 2F) and
immunofluorescence using antibodies against smooth muscle a-
actin (ACTA2) and cytokeratin 8 (KRT8)(Figure 2G–2L) as well as
calponin 1 (CNN1; Figure S1), a smooth muscle-specific protein
implicated in contraction.
Tgfbr1 cKO Mice Demonstrate Minimal Ovarian Defects
To define the causes of female sterility, we examined the ovaries
of the Tgfbr1 cKO mice. In contrast to the marked oviductal
phenotype, the ovaries of Tgfbr1 cKO mice were grossly normal
and contained follicles at various follicular stages (Figure S2A and
S2B). To address the cellular distribution of TGFBR1 in the
mouse ovary, we performed b-gal staining and found that
TGFBR1 was predominantly localized to the thecal layers of
developing follicles (Figure 3A), corpora lutea (Figure 3B), oocytes
(Figure 3B), and mural granulosa cells of preovulatory follicles
induced by gonadotropins (Figure 3C). TGFBR1 expression
signals in the granulosa cells of developing follicles and cumulus
cells of preovulatory follicles were close to the background level
(Figure 3A–3C). Furthermore, we found that GDF9 and its oocyte
paralog BMP15 reduced the expression of Tgfbr1 mRNA in mouse
granulosa cells cultured in vitro (Figure 3D).
Because development of preovulatory follicles occurred in
Tgfbr1 cKO mice exposed to exogenous gonadotropins (Figure
S2C and S2D), we examined cumulus expansion, a critical event
in ovulation, in these follicles. We found that cumulus cells from
the Tgfbr1 cKO mice underwent normal expansion both in vitro
and in vivo (Figure 3E–3K). We next conducted superovulation
analysis to evaluate ovulatory potential and found that Tgfbr1 cKO
Author Summary
Approximately 20% of infertile couples in the United States
have unexplained causes. Many vital aspects of female
fertility are regulated by a family of growth factors called
the transforming growth factor b (TGFb) superfamily.
These factors exert their functions via specific receptors
and downstream signal mediators. Perturbation of com-
ponents in this pathway can lead to reproductive
dysfunction. We identified a novel role for a TGFb receptor
(called TGFBR1) in female fertility. We demonstrated that
female mice with disruption of Tgfbr1 in the reproductive
tract are unable to successfully conceive, although they
can ovulate and produce fertilizable oocytes. Most
importantly, these mice have a striking deformity in the
oviduct, marked by the formation of oviductal outpouch-
ings (diverticula) that prevent embryos from reaching the
uterus. Concomitant aberrations in the uterine smooth
muscle layers are additional features of mice lacking
TGFBR1. Therefore, TGFBR1 is critical for the structural
integrity and function of the female reproductive tract. Our
model can be further exploited to study the development
of smooth muscle cells of the female reproductive tract.
Genetic mutations in TGFBR1 or other TGFb signaling
machinery may lead to fertility defects in women.
TGFBR1 Is Required for Female Fertility
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observed in these mice (Figure 3L). Similar to controls (Figure
S3A), the ovaries of the superovulated Tgfbr1 cKO mice contained
corpora lutea (Figure S3B), which were capable of synthesizing
3-b-hydroxysteroid dehydrogenase (3b-HSD) (Figure S3D). As
further evidence of the presence of functional corpora lutea in the
Tgfbr1 cKO mice, serum progesterone levels were comparable
between the control and Tgfbr1 cKO mice at 20 h after hCG
injection (gonadotropin primed immature mice) or at 3.5 days post
coitum (dpc; adult females) (Figure S3F). Moreover, oocytes could
be located and recovered from the oviductal diverticula of the
Tgfbr1 cKO mice and were fertilizable (Figure 3L).
TGFBR1, also known as activin receptor-like kinase 5 (ALK5),
had been proposed to mediate GDF9 signaling in vitro [35]. Based
on the lack of a prominent ovarian phenotype in the Tgfbr1 cKO
mice and the minimal, if any, expression of TGFBR1 in the
granulosa cells of preantral follicles, our results suggest that
TGFBR1 is at least not the sole physiological type 1 receptor for
GDF9 in mouse ovary. As an initial step toward exploring the
potential type 1 receptor(s) for GDF9, we performed in vitro studies
using Alk6 null granulosa cells as well as small molecule inhibitors
for ALK2/3/6 (Dorsomorphin; DM) and ALK4/5/7 (SB-505124;
SB). While dorsomorphin potently suppressed BMP15-induced
Ptx3 expression as expected (Figure 3Q), a dramatic effect of this
inhibitor on GDF9-induced Ptx3 expression was not observed
when GDF9 was applied at a concentration (15 ng/ml) that
induced Ptx3 mRNA expression with closer amplitude to that
stimulated by 100 ng/ml of recombinant BMP15 (Figure 3R).
Furthermore, GDF9 signaling remains intact in Alk6 null
granulosa cells as measured by the ability of GDF9 to induce
the expression of cumulus expansion-related transcripts such as
Ptx3 (Figure 3S). In contrast, the ALK4/5/7 inhibitor, SB-505124,
completely blocked the induction of Ptx3 in mouse granulosa cells
by GDF9 (Figure 3T). However, SB-505124 also reduced
recombinant BMP15-induced Ptx3 expression (data not shown),
potentially due to its effect on basal gene expression in mouse
granulosa cells. The above in vitro studies combined with our in vivo
Table 1. Fertility test of Tgfbr1 cKO mice.
Genotype n Pups/litter Litter/month
Tgfbr1




The Tgfbr1 cKO female mice were sterile during a 6-month breeding period
compared with control female mice lacking Amhr2
cre/+, which showed normal
fertility and fecundity. Data are presented as mean 6 SEM.
Data are presented as mean 6 SEM.
doi:10.1371/journal.pgen.1002320.t001
Figure 1. Generation of Tgfbr1 conditional knockout mice. (A) Schematic representation of the breeding strategy for generating Tgfbr1 cKO
and control mice. To ensure maximal deletion of Tgfbr1 and to visualize the localization of Tgfbr1 in the female reproductive tract, the Tgfbr1
bgal allele
was used in the breeding. (B) Illustration of the Tgfbr1 conditional allele with exon 3 flanked by two loxP sites. Primers Pa and Pc detect the
recombined allele of Tgfbr1. (C) Recombination of Tgfbr1 floxed alleles in the genomic DNA of Amhr2-Cre target tissues. The recombined bands were
detectable in the ovary (OV), oviduct (OT), and uterus (UT) of the Tgfbr1 cKO mice, but not in those of the controls and tail (TL) DNA samples. (D to F)
Relative Tgfbr1 mRNA levels in the granulosa cells (D; n=3), oviduct (E; n=5), and uterus (F; n=5) of control and Tgfbr1 cKO mice. Data are presented
as mean 6 SEM. *P,0.05 compared with controls.
doi:10.1371/journal.pgen.1002320.g001
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type 1 BMP receptors (ALK2/3/6), but more likely signals
through ALK4 and/or ALK7 in the mouse ovary.
Deleterious Effects of Oviductal Diverticula on Female
Fertility
Since ovulation and fertilization occurred in the Tgfbr1 cKO
and control females, we next assessed whether the formation of
oviductal diverticula was detrimental to embryo development
and/or transit of embryos to the uterus. After timed matings of
adult Tgfbr1 cKO females with proven fertile wild type (WT)
males, we could recover blastocysts (7.7560.63) at 3.5 dpc from
the uteri of controls (Figure 3M), but not Tgfbr1 cKO females
(Table 2). Instead, degenerating oocytes/embryos and their zona
pellucida remnants were recovered from the oviductal diverticula
(Figure 3N–3P), indicating that embryo development and embryo
transit to the uterus were severely compromised in the Tgfbr1 cKO
female mice. Since the oviduct is the site where sperm complete
their maturation and undergo capacitation [53], sperm transport
and/or capacitation could also be impeded in the adult Tgfbr1
cKO mice due to the severe oviductal phenotype.
Loss of TGFBR1–Mediated Signaling Results in Defective
Smooth Muscle Development in Mouse Uterus
Because TGFBR1 expression was also detected in smooth
muscle cells of the uterus (Figure 4A) where Amhr2-Cre activity is
Figure 2. Oviductal diverticula development in Tgfbr1 cKO mice. (A to F) Gross morphology (A to D) and b-gal staining (E and F) of oviducts
or oviductal diverticula in control and Tgfbr1 cKO mice. (G to L) Immunofluorescence of ACTA2 and KRT8 in the oviducts of 3-week-old control and
Tgfbr1 cKO mice. White arrowheads indicate the normal oviductal structure, while red arrowheads indicate oviductal diverticula. Odt, oviduct; Ova,
ovary; Ut, uterus; SM, smooth muscle; EP, epithelium. Scale bars=100 mm.
doi:10.1371/journal.pgen.1002320.g002
TGFBR1 Is Required for Female Fertility
PLoS Genetics | www.plosgenetics.org 4 October 2011 | Volume 7 | Issue 10 | e1002320present, we also examined the consequences of deletion of Tgfbr1
in the uterus. Grossly, the uteri of the Tgfbr1 cKO mice were
comparable in size to those of controls up through 3 months
(Figure S4A and S4B). However, the Tgfbr1 cKO uteri contained
multiple smooth muscle-defective areas, as evidenced by transil-
lumination (Figure 4B). By 8 months of age, the uterine pathology
in the Tgfbr1 cKO mice culminated in uterine cyst formation and
an almost unrecognizable mass of tissue (Figure 4C). The severely
disrupted smooth muscle structure was evident by immunostaining
of ACTA2 (Figure S4C–S4H) and CNN1 (Figure 4D–4I and
Figure S5). In contrast to controls (Figure 4D and 4G), the
myometrium of the Tgfbr1 cKO mice was disorganized with poorly
formed smooth muscle layers and intermingled with the
endometrial components (Figure 4E, 4F, 4H, and 4I). Our data
Figure 3. Cellular distribution and functional characterization of TGFBR1 in mouse ovary. (A to C) b-gal staining of ovaries from immature
[(A; untreated) and (C; PMSG-hCG treated)] and adult (B) Tgfbr1
+/bgal mice. (D) Suppression of Tgfbr1 mRNA in mouse granulosa cells by recombinant
BMP15 or GDF9 after 5 h treatment (n=3). (E to H) Expansion of COCs from control and Tgfbr1 cKO mice in vitro in the absence (E and G) or presence
(F and H) of EGF (10 ng/ml). (I) Cumulus expansion index (CEI) of the in vitro cultured COCs from control (n=4) and Tgfbr1 cKO (n=5) mice. (J and K)
Preovulatory follicles from Tgfbr1 cKO mice demonstrating cumulus expansion. PF, primary follicle; SF, secondary follicle; AF, antral follicle; Oo, oocyte;
TC, thecal cell; GC, granulosa cell; CC, cumulus cell; CL, corpus luteum; COC, cumulus-oocyte complex. Scale bars=50 mm (J and K); 100 mm (A and C);
and 200 mm (B). (L) Ovulation and oocyte fertilization potential of Tgfbr1 cKO mice (n=8–10). (M to P) Blastocysts or degenerated oocytes/embryos
recovered from control (M) and Tgfbr1 cKO mice (N to P). (Q to T) Identification of receptor preference for GDF9 signaling in mouse granulosa cells
using small molecule inhibitors and Alk6
2/2 granulosa cells. Dorsomorphin (DM; 4 mM) was preincubated with granulosa cells for 1 h before BMP15
(100 ng/ml) or GDF9 (15 ng/ml) was added. DM markedly reduced Ptx3 induction by BMP15 (Q), while a similar effect was not observed on GDF9-
induced Ptx3 mRNA expression (R). Induction of Ptx3 mRNA by GDF9 (100 ng/ml) was not attenuated in Alk6
2/2 granulosa cells (S). However, SB-
505124 (SB; 1 mM) suppressed GDF9-induced Ptx3 mRNA expression (T). Con, control. n=3 for each group. Relative mRNA levels of Tgfbr1 and Ptx3
were normalized to Gapdh. Data are presented as mean 6 SEM. Bars without a common letter are significantly different at P,0.05.
doi:10.1371/journal.pgen.1002320.g003
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defective smooth muscle development in the oviduct and uterus.
To determine if the disorganization of uterine smooth muscle
layers can affect stromal cell function, we performed an artificial
decidualization study. Both the control and Tgfbr1 cKO mice
demonstrated responses to uterine scratches (Figure S6A and S6B).
To quantitatively compare the decidual response between the
control and Tgfbr1 cKO groups, we calculated the weight ratio of
stimulated (scratched) horn versus unstimulated horn. There was
no significant difference between the two groups (Figure S6C;
P.0.05), although disrupted uterine smooth muscle layers were
visualized by immunostaining of CNN1 (Figure S6D–S6G). These
results suggest that the compromised smooth muscle development
in Tgfbr1 cKO uterus does not prevent the uterine decidual
response, although the decidualization occurs in an overall
abnormal uterine environment where stromal cells were segregat-
ed by dispersed smooth muscle structure.
Smooth Muscle Gene Expression in Tgfbr1 cKO Oviducts
To examine if loss of TGFBR1 affects the expression of smooth
muscle genes, we compared the mRNA levels of select genes
between control and Tgfbr1 cKO oviducts from 3–4 week old mice.
Accompanying the defective smooth muscle phenotype, transcript
levels of all smooth muscle genes examined, including Acta2, Cnn1,
transgelin (Tagln), smoothelin (Smtn), smooth-muscle myosin heavy
chain (Myh11), and desmin (Des), were reduced in the oviducts of
Tgfbr1 cKO mice compared with controls (Figure 5A). Concomi-
tantly, the mRNA level of myocardin (Myocd), a smooth muscle and
cardiac muscle-specific transcriptional co-activator and a master
modulator of smooth muscle gene expression [54], was also
decreased in the Tgfbr1 cKO oviducts (Figure 5B).
Interestingly, a similar oviductal phenotype was also observed
in the Amhr2-Cre mediated conditional deletion of DICER1
[51,52,55], the RNase III involved in microRNA (miRNA)
processing in cytoplasm. A recent study [56] demonstrated that
TGFb signaling can induce the maturation of a subset of miRNAs.
An intriguing question was whether TGFb signaling is linked to
Table 2. Embryo recovery from 3.5 dpc uteri of control and
Tgfbr1 cKO mice.
Genotype Dpc n No. of embryo
Tgfbr1
flox/bgal 3.5 4 7.7560.63
Tgfbr1
flox/bgal; Amhr2
cre/+ 3.5 5 0
After timed matings, blastocysts could be recovered at 3.5 dpc from the uteri of
controls, but not Tgfbr1 cKO females. Data are presented as mean 6 SEM.
Data are presented as mean 6 SEM.
doi:10.1371/journal.pgen.1002320.t002
Figure 4. Tgfbr1 cKO mice demonstrate disrupted uterine smooth muscle development. (A) Localization of TGFBR1 to myometrium by
b-gal staining. (B and C) Gross uterine morphology of control and Tgfbr1 cKO mice. Blue arrows and arrowheads indicate the respective oviductal
diverticula and the smooth muscle defective areas, whereas red arrows point to uterine cysts. (D to I) Immunostaining of CNN1 in the uteri of control
(D and G) and Tgfbr1 cKO (E, F, H, and I) mice. LM, longitudinal muscle layer; CM, circular muscle layer; Ova, ovary; Ut, uterus. Red arrowheads point to
disorganized uterine smooth muscle structures. Scale bars=50 mm (G and H); 100 mm (A and I); 200 mm (D to F); and 5 mm (C).
doi:10.1371/journal.pgen.1002320.g004
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that two newly identified vascular smooth muscle associated
miRNAs, miR-143 and miR-145 [57–60], were down-regulated in
the oviducts of Tgfbr1 cKO mice (Figure 5C). However, miR-21,a
known target of TGFb ligands [56], was not significantly affected
in the Tgfbr1 cKO oviducts (Figure 5C). Moreover, the
downstream targets of miR-143/145 (i.e., transcription factors
Elk1, Klf4, and Camk2d) were not altered in the oviducts of Tgfbr1
cKO mice (Figure S7).
Since the smooth muscle genes and miR-143/145 were
predominantly expressed in the smooth muscle compartments,
loss of smooth muscle tissues in the oviducts during the formation
of oviductal diverticula could potentially lead to reduced
expression of smooth muscle genes or associated miRNAs in the
Tgfbr1 cKO oviducts. To address this possibility, we collected and
analyzed postnatal day 7 oviducts prior to significant smooth
muscle loss. However, dramatic reductions in the expression of
smooth muscle genes and miR-143 and miR-145 were not detected
at this stage (data not shown).
Tgfbr1 cKO Mice Develop a Uterine Phenotype Distinct
from Dicer1 cKO Mice
Despite the occurrence of oviductal diverticula in both Tgfbr1
cKO and Dicer1 cKO mice, we found that the uterine phenotype
of Tgfbr1 cKO mice is distinct from that of the Dicer1 cKO mice.
Consistent with our previous report [55], Dicer1 cKO mice have
smaller uteri than controls (Figure 6A and 6B), as is in contrast
to Tgfbr1 cKO mice. Unlike Tgfbr1 cKO mice (Figure 6F),
immunostaining showed that mice with a conditional deletion of
Dicer1 developed normal smooth muscle layers (Figure 6B and 6D).
The divergence in the uterine phenotypes between Tgfbr1 cKO
and Dicer1 cKO mice also suggests that the development of
oviductal diverticula in these two mouse models may not be in a
linear pathway. As further support of this concept, we found that
mRNA levels for genes up-regulated in Dicer1 cKO oviducts
(Wnt5a, Wnt7a, Hoxa9, Hoxa10, etc.) [55] were not increased in
Tgfbr1 cKO mice (Figure S8).
Molecular Alterations in the Oviduct of Tgfbr1 cKO Mice
To further study the molecular basis of the striking oviductal
diverticulum phenotype in Tgfbr1 cKO mice, we performed real-
time PCR analyses of oviducts from postnatal day 7 mice. We
herein uncovered the dysregulation of candidate genes in the
Tgfbr1 cKO oviducts that are associated with cell differentiation
(Krt12 and MyoR) and migration (Ace2, Vegfa, and Figf ).
The keratins are intermediate filament proteins that are
important structural components of epithelial cells [61,62]. In
the Tgfbr1 cKO oviducts, expression of Krt12, a member of the
keratins, was markedly reduced (P,0.05; Figure 7). Another
epithelial gene, the oviductal glycoprotein 1 (Ovgp1), was also
down-regulated (P,0.05; Figure 7). The altered expression of
epithelial genes suggests the importance of TGFBR1–mediated
signaling in the maintenance of the mesenchymal-epithelial
interactions critical for oviductal development.
TGFb signaling can regulate the differentiation of vascular
smooth muscle cells [63–65]. We found that mRNA encoding the
Figure 5. Dysregulation of smooth muscle genes and miR-143 and miR-145 in the oviducts of Tgfbr1 cKO mice at 3–4 weeks of age. (A)
Global reduction of smooth muscle gene transcripts in the oviducts of Tgfbr1 cKO mice. (B) Down-regulation of Myocd mRNA in the Tgfbr1 cKO
oviducts. (C) Alterations of miR-143 and miR-145, but not miR-21, in the oviducts of Tgfbr1 cKO mice. Relative mRNA levels of smooth muscle genes (A)
and Myocd (B) were normalized to Gapdh, while levels of miR-143, miR-145, and miR-21 (C) were normalized against snoRNA202. n=3–5 independent
pools of oviducts. Data are presented as mean 6 SEM. *P,0.05 versus controls.
doi:10.1371/journal.pgen.1002320.g005
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(bHLH) transcription factor, MyoR/musculin, was increased more
than 4-fold in Tgfbr1 cKO oviducts versus controls (P,0.05;
Figure 7).
Overexpression of angiotensin-converting enzyme 2 (ACE2), a
member of the renin-angiotensin system, is associated with cell
migration [66]. In the Tgfbr1 cKO oviducts, the expression of Ace2
mRNA was markedly increased in the Tgfbr1 cKO oviducts
(P,0.05; Figure 7). Even at 21 days of age, levels of Ace2 mRNA
were consistently higher in Tgfbr1 cKO oviducts than controls
(data not shown). Other migration related genes such as vascular
endothelial growth factor A (Vegfa) and c-fos induced growth factor
(Figf/Vegfd) were also up-regulated in the Tgfbr1 cKO oviducts
(P,0.05; Figure 7).
Discussion
Despite the progress made on functional characterization of
TGFb family ligands in female reproduction, the in vivo roles of
individual receptors in this pathway have remained elusive.
Because conventional inactivation of Tgfbr1 results in embryonic
lethality [44], the functional understanding of this receptor in
female reproductive tissues was hampered. In the current study,
Figure 6. Distinct uterine phenotypes between Dicer1 cKO and Tgfbr1 cKO mice. (A–D) Adult Dicer1 cKO mice (B and D) have smaller uteri
but normal smooth muscle structure compared with controls (A and C) by immunostaining of uterine cross sections with CNN1. (E and F) Disruption
of uterine smooth muscle layers in Tgfbr1 cKO mice (F; arrowheads) versus controls (E) by immunostaining of uterine longitudinal sections with CNN1.
doi:10.1371/journal.pgen.1002320.g006
Figure 7. Dysregulation of genes in the oviducts from
postnatal day 7 Tgfbr1 cKO mice. Real-time PCR analyses using
oviducts from postnatal day 7 mice demonstrated down-regulation of
Krt12 and Ovgp1 and up-regulation of MyoR, Ace2, Vegfa, and Figf in
Tgfbr1 cKO mice (n=5 independent pools of oviducts) versus controls
(n=5 independent pools of oviducts). Relative mRNA levels were
normalized to Gapdh. Data are presented as mean 6 SEM. *P,0.05
versus respective controls.
doi:10.1371/journal.pgen.1002320.g007
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using Amhr2-Cre expressed in granulosa cells and mesenchymal
compartments of the oviduct and uterus [51,55] led to female
sterility. Histological analysis revealed that Tgfbr1 cKO mice had
minimal defects in their ovaries, which contain morphologically
normal follicles at various developmental stages. To determine if
the Tgfbr1 cKO mice have normal ovarian function, we conducted
superovulation and fertilization experiments. Our results showed
that Tgfbr1 cKO mice could ovulate, and the ovulated oocytes
were fertilizable. These data suggest that TGFBR1 in mouse
granulosa cells may not be essential for ovulation and oocyte
fertilization.
TGFBR1 can mediate GDF9 signaling in granulosa cells in vitro
[35]. Since GDF9 regulates folliculogenesis and cumulus cell
expansion [12,36,42,67], we were interested to know if cumulus
cell function was impaired in the Tgfbr1 cKO mice. We found that
Tgfbr1 cKO cumulus cells could expand in vivo and in vitro.
Moreover, TGFBR1 was predominantly localized to thecal cells
and corpora lutea, but not granulosa cells of developing follicles at
preantral stage, the known sites for GDF9 action. After PMSG-
hCG injection, the mural granulosa cells but not cumulus cells of
preovulatory follicles highly expressed b-galactosidase from the
Tgfbr1
bgal knockin allele. Recombinant GDF9 or BMP15, another
oocyte-derived factor implicated in follicular development [68–
70], could markedly reduce Tgfbr1 expression in mouse granulosa
cells, which might explain the low intensity of TGFBR1 signals in
cumulus cells adjacent to the oocyte. The data indicate that
TGFBR1 might not be a physiological receptor for GDF9, or at
least not the sole GDF9 type 1 receptor in mouse ovarian somatic
cells. To further explore the potential GDF9 type 1 receptor(s) in
mouse ovary, we utilized mouse granulosa cell culture and took
advantage of Alk6 null granulosa cells and small molecule
inhibitors for ALK2/3/6 [71] and ALK4/5/7 [72]. Consistent
with ALK6 as the BMP15 type 1 receptor [73,74], the ability of
recombinant BMP15 to induce cumulus expansion-related
transcript expression is completely lost in mouse granulosa cells
lacking ALK6 (data not shown). However, GDF9 signaling
remains intact in Alk6 null cells, excluding ALK6 as a GDF9
receptor. The small molecule inhibitor studies further helped to
identify potential candidate receptors for GDF9 in mouse ovary
(i.e., ALK4 and/or ALK7), although SB-505124 cannot precisely
distinguish the type 1 receptor through which GDF9 signals.
Despite these findings, future functional studies using conditional
deletion of one or more type 1 receptors are needed to pinpoint
the physiological receptor(s) for GDF9 in mouse ovary.
Because Amhr2 is also expressed in mesenchyme-derived tissues
in the oviduct and uterus [75], we examined whether the observed
sterility is a phenotypic consequence of conditional knockout of
Tgfbr1 in the oviduct and/or uterus. We found that the Tgfbr1
cKO mice develop a striking oviductal phenotype marked by the
formation of bilateral diverticula. Histologically, a well-formed
diverticulum comprises a single layer of smooth muscle cells and
epithelium. The presence of degenerating oocytes/embryos in the
oviductal diverticula but absence of blastocysts in the uteri
(3.5 dpc) of the Tgfbr1 cKO mice strongly indicate that
development of oviductal diverticula is sufficient to cause female
infertility in the Tgfbr1 cKO mice, though it is plausible that
disruption of the uterine smooth muscle development might
sequentially confound the pregnancy outcome if pregnancy could
occur in these mice. It is known that the myometrium plays an
important role in key pregnancy-associated reproductive events,
although current knowledge of myometrial causes of reproductive
disorders is limited [76]. A successful labor is dependent on the
synchronous myometrial contractions, which are regulated by a
series of coordinated events at both hormonal and molecular levels
during pregnancy [77,78]. The disruption of uterine smooth
muscle structure in the Tgfbr1 cKO mice could potentially impede
the contractility of the uterus or cause uterine rupture, with an
adverse impact on pregnancy outcome. Emerging evidence suggests
the involvement of the Wnt pathway in the maintenance of
myometrium organization and integrity [79,80]. Further investiga-
tions on the potential link between TGFBR1–mediated signaling
and the Wnt pathway as well as the direct impact of the myometrial
abnormalities resulting from loss of TGFb/Wnt signaling compo-
nents on reproductive potential may shed mechanistic light on
reproductive disorders associated with smooth muscle pathology.
It is noteworthy that the oviductal phenotype of the TGFBR1-
deficient mice resembles that of the conditional deletion of Dicer1,
a key gene involved in miRNA and small interfering RNA (siRNA)
biogenesis pathways [81]. MicroRNAs are non-coding small
RNAs that regulate gene expression by inducing translational
repression or mRNA degradation of target genes [81]. Recent
studies in vascular smooth muscle cells suggest that TGFb
signaling can induce the maturation of a subset of miRNAs
through the interactions between SMADs and the consensus RNA
sequence of miRNAs within the DROSHA microprocessor
complex [56,82,83]. Based on these findings and the similarity
of the oviductal phenotype between Tgfbr1 and our previously
described Dicer1 cKO mice [55], we proposed a potential link
between the TGFb signaling and miRNA pathways in the female
reproductive tract. To test this hypothesis, we examined the
expression of select genes/miRNAs in the oviducts of 3–4 week old
Tgfbr1 cKO and control mice. We found a global reduction of
expression of smooth muscle genes, as well as two miRNAs, miR-
143 and miR-145, in the Tgfbr1 cKO oviducts compared with
controls. These two miRNAs are expressed in smooth muscle cells
and have debatable roles in specifying smooth muscle phenotype
[57–60,84]. However, miR-21, which is regulated by TGFb
signaling in vascular smooth muscle cells [56], was not altered in
the Tgfbr1 cKO oviducts. The defective oviductal smooth muscle
phenotype of the Tgfbr1 cKO mice raised the possibility that the
reductions of smooth muscle genes and smooth muscle associated
miRNAs could be a consequence of reduced muscle components
in the oviductal samples. To further address this question, we
collected and analyzed oviductal samples from both control and
Tgfbr1 cKO mice at the age of 7 days prior to significant smooth
muscle loss. We confirmed by quantitative PCR that miR-143 was
not significantly altered in the Tgfbr1 cKO oviducts. Consistently,
alteration of smooth muscle gene expression was not found in
7-day-old oviducts of Tgfbr1 cKO mice. Therefore, the decreased
expression of miR-143/145 and smooth muscle genes in the 3–4
week old Tgfbr1 cKO mice is likely caused by reduced smooth
muscle components. Although Dicer1 cKO mice develop oviductal
diverticula [55], they have distinct uterine phenotypes (i.e., small
uteri but histologically normal smooth muscle layers) and oviductal
gene expression patterns compared to the Tgfbr1 cKO mice.
Moreover, the phenotype of Tgfbr1 cKO mice is distinct from that
of conditional deletion of Smad2 and Smad3 [18], suggesting the
involvement of SMAD-independent pathway(s) downstream of
TGFBR1. Collectively, the oviductal phenotype observed in
Tgfbr1 cKO mice is likely not a direct consequence of miRNA
dysregulation.
Molecular analysis of the postnatal day 7 oviducts from Tgfbr1
cKO mice demonstrated dysregulation of genes associated with
cell differentiation and migration. Keratins have recently been
highlighted as vital regulators of diverse cellular properties and
functions (e.g., apico-basal polarization, motility, etc.), rather than
simple epithelial markers [62]. KRT12 is a member of epithelial
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of keratins (type 1 and type 2) as heterodimeric polymers [61,62].
Dysregulation of epithelial genes in the oviducts of Tgfbr1 cKO
mice suggests that mesenchymal-epithelial interactions, which are
potentially vital for smooth muscle development [85], could be
affected when TGFBR1–mediated signaling is disrupted in the
smooth muscle compartment although potentially functional
TGFBR1 might still be present in the epithelial compartment
due to the lack of Amhr2-Cre activity. As evidence of potentially
altered smooth muscle cell differentiation, we found that MyoR/
musculin was substantially up-regulated in the Tgfbr1 cKO
oviducts. Despite the fact that MyoR is also expressed in other
cell types and can regulate their differentiation [86], the
significance of MyoR up-regulation in Tgfbr1 cKO oviducts awaits
further investigation as current understanding of MyoR-regulated
cell differentiation has been confined to the skeletal muscle lineage
[87]. Beyond the aspects of cell differentiation, our data also point
to the potential aberration of cell migration in the Tgfbr1 cKO
oviducts. It is well established that the renin-angiotensin system
serves as a physiological system regulating blood pressure. Renin
catalyzes the conversion of angiotensinogen to angiotensin I,
which can be converted by ACE into angiotensin II. ACE2 is a
newly described member of the renin-angiotensin system that can
cleave angiotensin II into angiotensin 1–7, or angiotensin I into
angiotensin 1–9 [66]. The renin-angiotensin system has been
implicated in vascular smooth muscle cell proliferation and
migration [88,89], and ACE2 overexpression-induced alterations
in cell migration have been documented [88]. In further support of
aberrant cell migrations in the Tgfbr1 cKO oviducts, we found
increased expression of Vegfa and Figf/Vegfd. VEGFA and VEGFD
are known regulators of smooth muscle cell migration [90,91], and
VEGF receptors are expressed in vascular smooth muscle cells
[92]. Interestingly, Vegf is induced by TGFb in mouse macro-
phages [93]. However, given the highly context-dependent nature
of gene regulation by TGFb signaling [94] as well as the diversity
of ligands which signal via TGFBR1, it is not surprising that Vegf is
up-regulated in mouse oviducts lacking TGFBR1. Moreover, it is
not clear if the dysregulation of the aforementioned genes in the
oviducts are direct or indirect effects of the loss of TGFBR1. Thus,
our results indicate that profound molecular changes may occur in
the smooth muscle and/or epithelial compartments of the oviduct
in the absence of TGFBR1–mediated signaling. These alterations
may developmentally affect the structural, migratory, and
differentiating properties of the smooth muscle/epithelial cells,
ultimately leading to the formation of the deleterious oviductal
diverticula.
In summary, this study provides genetic evidence that
TGFBR1–mediated signaling controls the integrity and function
of the female reproductive tract. Disruption of TGFBR1–
mediated signaling leads to catastrophic structural and functional
consequences. Further in-depth understanding of the functional
and regulatory significance of TGFBR1–mediated signaling in
female reproductive physiology and pathology may help to
discover novel therapeutic approaches for infertility treatment.
Materials and Methods
Ethics Statement
All mouse lines were manipulated according to the NIH Guide
for the Care and Use of Laboratory Animals. All procedures have
been approved by the Institutional Animal Care and Use
Committee (IACUC) at Baylor College of Medicine. We took
all necessary steps to minimize suffering of mice during the
experiments.
Animals and Cell Lines
All mouse lines were maintained on a mixed genetic
background (C57BL/6/129S6/SvEv). The Tgfbr1
flox allele was
constructed by flanking the Tgfbr1 exon 3 which encodes the
transmembrane domain and the glycine/serine-rich (GS) domain
withtwo loxPsites[44].MiceharboringaTgfbr1
bgalallele(nullallele)
were generated and characterized by Deltagen and obtained from
the Jackson laboratory. The function of the Tgfbr1 gene was
disrupted by insertion of a bacterial LacZ into the Tgfbr1 gene
(http://jaxmice.jax.org/strain/005847.html). The Amhr2
cre/+ mice
were created by inserting a Cre-Neo cassette into the fifth exon of
the Amhr2 locus [48]. HEK-293 and HEK-293T cells were obtained
from the Tissue Culture Core at Baylor College of Medicine. Dicer1
cKO mice were generated as previously described [55].
Production of Purified Recombinant BMP15 and GDF9
Recombinant human BMP15 was produced from HEK-293
stable cell lines as described previously [95]. Recombinant mouse
GDF9 was constructed, produced, and purified using a similar
strategy for engineering recombinant human BMP15 [95]. Briefly,
we cloned the mouse GDF9 cDNA from 3-week old mouse
ovaries. PCR-based mutations and introduction of restriction sites
were performed using Phusion Hot Start High-Fidelity DNA
polymerase (Finnzymes). Optimization of the cleavage and
surrounding sequence (SHRSKRSLSGG) and introduction of a
FLAG-tag (DYKDDDDK) were conducted by using overlap
extension PCR. The genetically modified GDF9 sequence was
cloned into pEFIRES-P, a bicistronic expression vector driven by
human polypeptide chain elongation factor 1a promoter [96]. The
GDF9 expression construct was then transfected into HEK-293T
cells, and cell clones stably expressing recombinant GDF9 were
selected in the presence of puromycin (Invitrogen) and used for the
production of recombinant proteins. As a rigorous control for the
purified recombinant GDF9, a ‘‘control buffer’’ was produced
from the culture medium of non-transfected cells under the same
purification approach as previously described [95].
Generation of Tgfbr1 cKO Mice
Using a Cre-loxP system [55], we first generated Tgfbr1
+/bgal;
Amhr2
cre/+ mice. We subsequently crossed these mice with
Tgfbr1
flox/flox (homozygotes) to produce mice with the following
genotypes: Tgfbr1
flox/bgal; Amhr2
cre/+ (cKO; experimental mice)
and controls (Tgfbr1
flox/bgal and Tgfbr1
flox/+). For the fertility tests,
each female cKO or control mouse was caged with a WT male
with known fertility at the age of 6 weeks for a 6-month period.
The genotypes of the mice were analyzed by PCR using gene
specific primers (Table 3).
Histology and b-Gal Staining
For histological studies, mouse samples (ovaries, oviducts, and
uteri) were fixed in 10% neutral buffered formalin (NBF)
overnight. The samples were washed with 70% ethanol and
embedded in paraffin by the Pathology Core Services Facility at
Baylor College of Medicine. The samples were further processed
for hematoxylin and eosin (H&E) or periodic acid Schiff (PAS)-
hematoxylin staining using standard procedures.
For b-gal staining, mouse samples were fixed in fixation solution
(2% paraformaldehyde, 0.2% glutaraldehyde, and 0.1 M phos-
phate pH 7.4) for 10–15 min. The samples were then rinsed 3
times for 30 min each in rinse buffer (0.01% sodium deoxycholate,
0.02% NP-40, 2 mM MgCl2, and 0.1 M phosphate pH 7.4). The
b-gal staining was performed overnight at room temperature in
staining buffer (0.01% sodium deoxycholate, 0.02% NP-40, 2 mM
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anide, 1 mg/ml X-gal, and 0.1 M phosphate pH 7.4). After
staining, the samples were fixed in 10% NBF for at least 4 h,
washed with 70% ethanol, and processed for sectioning. The
sections were counterstained with fast red (Vector lab).
Immunohistochemistry and Immunofluorescence
Paraffin-embedded sections (5 mm) were deparaffinized in
xylene and rehydrated in graded alcohol. Antigen retrieval was
performed by boiling the sections in 10 mM citrate buffer
(pH 6.0) for 20 min. To quench endogenous peroxidase, the
sections were treated with 0.3% (v/v) hydrogen peroxide, and
then blocked with 3% goat serum for 30 min, followed by
incubation with rabbit anti smooth muscle a-actin (Abcam; 1:500)
or rabbit anti-calponin 1 (Millipore; 1:200) at 4uCo v e r n i g h t .A f t e r
primary antibody incubation, the sections were washed and
sequentially incubated with biotinylated anti-rabbit IgG and ABC
reagent (Vector Labs). Immunoreactive signals were developed
Table 3. Primers for conventional PCR and SYBR green-based real-time PCR.
Name Sequence (59-39) Reference
Tgfbr1 flox Forward ACTCACATGTTGGCTCTCACTGTC [102]
Reverse AGTCATAGAGCATGTGTTAGAGTC
Tgfbr1 +/2 moIMR0003 GGGCCAGCTCATTCCTCCCACTCAT Tgfbr1
tm1Dgen
moIMR0843 CCTGTGGAGCTGGCAGCTGTCATTG Jackson lab
moIMR0844 ACTATCCGGGTCAGACAGCAAGCTC
Tgfbr1 Rec Forward ATTTCTTCTGCTATAATCCTGCAG [102]
Reverse AGTCATAGAGCATGTGTTAGAGTC
Amhr2 Cre Forward CGCATTGTCTGAGTAGGTGT [18]
Reverse GAAACGCAGCTCGGCCAGC
Hprt Forward GGACCTCTCGAAGTGTTGGATAC N/A
Reverse CTTGCGCTCATCTTAGGCTT
Tagln Forward CGATGGAAACTACCGTGGAGA [55]
Reverse TGAAGGCCAATGACGTGCT
Acta2 Forward CCACCGCAAATGCTTCTAAGT [55]
Reverse GGCAGGAATGATTTGGAAAGG
Cnn1 Forward GGTGAAACCCCACGACATCTT [55]
Reverse TTTGTCTTGGCCATGCTGG
Camk2d Forward CAGCAGGCATGGTTTGGTT N/A
Reverse CATAAGGATCTTTACGCAGGACTTC
Myh11 Forward CATCCTGACCCCACGTATCAA [55]
Reverse ATCGGAAAAGGCGCTCATAGG
Des Forward TACACCTGCGAGATTGATGCC [55]
Reverse GCGCAATGTTGTCCTGATAGC
Smtn Forward TCACTACCTTCAGCCATGCCT [55]
Reverse GCCATTAGCTGCTTCCACTGT
Gapdh Forward CAATGTGTCCGTCGTGGATCT [55]
Reverse GCCTGCTTCACCACCTTCTT
Tgfbr1 Forward TGCCATAACCGCACTGTCA N/A
Reverse AATGAAAGGGCGATCTAGTGATG
Myocd Forward CCAACACCTTGCCCAGTTATC N/A
Reverse GGAGCTTGTGCTGCCAAAG
Hoxa9 Forward CCTTCTCCGAAAACAATGCC [55]
Reverse TCCTTCTCCAGTTCCAGCGT
Hoxa10 Forward TGGAGAAGGAGTTTCTATTCAACATG N/A
Reverse TGGACGCTACGGCTGATCT
Elk1 Forward CATGACAGCCACGAATATGAAGA N/A
Reverse TCTGACATATGCCATCATTTTGC
Klf4 Forward CTCACACAGGCGAGAAACCTT N/A
Reverse GAGCGGGCGAATTTCCA
Primer sequences are listed along with available references. All real-time PCR primers were designed using Primer Express software (Applied Biosystems).
doi:10.1371/journal.pgen.1002320.t003
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counterstained with hematoxylin.
Immunofluorescence was conducted using a similar protocol
except that the hydrogen peroxide treatment was omitted and the
secondary antibodies were Alexa fluor 488 (Invitrogen) and Alexa
fluor 555 (Molecular Probes). The rat anti-cytokeratin-8 antibody
was obtained from the Developmental Studies Hybridoma Bank
(DSHB). The sections were mounted with Vectashield mounting
medium containing DAPI.
Superovulation, Embryo Culture, and Timed Mating
Superovulation experiments were performed to assess the
ovulatory potential of the Tgfbr1 cKO mice as described [18,46].
In brief, the gonadotropin-primed female Tgfbr1 cKO and control
mice were mated with WT males. The cumulus-oocyte complexes
(COCs) were recovered, exposed to M2 medium containing
1 mg/ml hyaluronidase, and counted. They were then cultured in
M16 medium (Sigma). The number of embryos at the 2-cell stage
was determined and recorded at the end of culture [55]. For timed
matings, the control and Tgfbr1 cKO females (6–8 week old) were
mated with WT males, and copulatory plugs were checked the
next morning. The oocytes or embryos were collected at 3.5 dpc
from the oviducts or uteri.
Hormone Analyses
Blood samples were collected by cardiac puncture from mice
anesthetized with isoflurane. The serum was separated from the
blood and stored at 220uC until assayed. Serum progesterone (P4)
levels were measured by the Ligand Assay and Analysis Core at
the Center for Research in Reproduction, University of Virginia.
The detection limit was 0.1 ng/ml. Assay details can be found at
http://www.healthsystem.virginia.edu/internet/ crr/ligand.cfm.
Cumulus Expansion Assays
Cumulus expansion analysis was conducted as previously
described [18]. For in vitro cumulus expansion assay, the COCs
were collected and cultured in the presence or absence of
epidermal growth factor (EGF; 10 ng/ml). Cumulus expansion
was examined after 16 h of culture and scored. The cumulus
expansion index (CEI) was calculated based on the degree of COC
expansion using a scale from 0 (no expansion) to 4 (complete
expansion) [97]. For in vivo cumulus expansion analysis, immature
mice (21–23 d) were treated with PMSG (46 h) and hCG (7 h).
The ovaries were collected and processed for PAS staining, and
the preovulatory follicles were examined microscopically for
cumulus cell expansion.
Primary Granulosa Cell Culture
Immature WT or Alk6 null female mice [98,99] were treated
with 5 IU PMSG (i.p.). Large antral follicles were punctured to
collect granulosa cells after 44–46 h [18,95]. The cells were
filtered through a 40 mm nylon mesh (Becton, Dickinson and
Company), washed, and resuspended for the following experi-
ments. (1) Tgfbr1 mRNA regulation by oocyte-produced factors:
The WT mouse granulosa cells were treated with control buffer
[95], recombinant BMP15 (100 ng/ml), or recombinant GDF9
(100 ng/ml). The cells were collected in lysis buffer after 5 h
treatment. (2) Gene induction assay (Ptx3): The WT and Alk6 null
granulosa cells were collected and treated with recombinant
BMP15 (100 ng/ml) or GDF9 (100 ng/ml), and the cells were
collected 5 h later. (3) Small molecule inhibitor assay: Mouse
granulosa cells were preincubated for 1 h with dorsomorphin
(Calbiochem; 4 mM) or SB-505124 (Sigma; 1 mM), and BMP15 or
GDF9 was then added to the culture and further incubated for 5 h
before the cells were collected. Total RNA was isolated from the
cells harvested in the above experiments, and real-time PCR
analyses were performed to determine the Tgfbr1 or Ptx3 mRNA
expression.
Reverse Transcription, Real-Time PCR, and microRNA
Analysis
Total RNA from mouse granulosa cells, oviducts, or uteri was
isolated using Qiagen RNeasy Micro or Mini Kit. Two hundred
nanograms of total RNA were reverse transcribed using
Superscript III reverse transcriptase (Invitrogen) [95]. Real-time
PCR was performed using Taqman gene expression assay
(Applied Biosystems) and Taqman PCR Master Mix or custom-
ized primers and SYBR green master mix [55]. Primer
information is listed in Table 3 and Table 4.
For microRNA analysis, total RNA was isolated from mouse
oviducts using mirVana miRNA isolation kit (Ambion). Levels of
mature miRNA were measured using a two-step TaqMan
MicroRNA Assay (Applied Biosystems). First, reverse transcription
was performed using 10 ng of total RNA and stem-loop primers
specific for miR-143, miR-145, and miR-21. Then, quantitative
real-time PCR was conducted using specific Taqman probes for
these miRNAs and Taqman universal PCR master mix (No
AmpErase UNG).
Real-time PCR was carried out based on a protocol consisting
of 40 cycles: 95uC for 10 min (hold), 95uC for 15 s (denature), and
60uC for 1 min (anneal/extend). All real-time PCR assays were
performed in duplicate or triplicate for each sample. Gapdh was
used as an internal control for the quantification of gene
expression, while snoRNA202 was used for normalization of
miRNA levels. Relative mRNA abundance was calculated using
DDCT method [100].
Uterine Decidualization
The uterine decidualization experiment was performed as
described elsewhere [101]. Briefly, adult Tgfbr1 cKO and control
mice were subjected to ovariectomy followed by 3 days of estradiol
treatment (100 ng/mouse) and 2 days of rest. The mice were
subsequently treated with both estradiol (6.7 ng/mouse) and
progesterone (1.0 mg/mouse) for 3 days. To artificially induce
uterine decidualization, one uterine horn was traumatized/
scratched using a needle on the antimesometrial side. The other
uterine horn was not traumatized and used as a control. After that,
the mice were continuously primed with estradiol and progesterone
Table 4. Taqman gene expression and miRNA assays.









Taqman assays were obtained from Applied Biosystems, and assay names and
their corresponding IDs are listed.
doi:10.1371/journal.pgen.1002320.t004
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and the tissues were collected and fixed in paraformaldehyde for
histological and immunohistochemical assays.
Statistical Analyses
A one-way analysis of variance (ANOVA) was applied to
determinethedifferenceofmeansamonggroups, andthe difference
between two means was further assessed by Tukey’s HSD test.
Comparison of means between two groups was conducted using
t-test. Data are presented as mean 6 standard error of the mean
(SEM). Statistical significance was defined at P,0.05.
Supporting Information
Figure S1 Tgfbr1 cKO mice have defective smooth muscle
formation in the oviduct. (A to C) Calponin 1 is expressed in the
smooth muscle layers of the control oviduct (A and B). Negative
control in which the primary antibody was substituted with rabbit
IgG is shown in (C). (D to F) Defective smooth muscle formation in
the oviducts of Tgfbr1 cKO mice. Higher magnification view of the
selected regions within the blue and red rectangles in (D) were
depicted in (E) and (F), respectively. Arrowheads demonstrate
smooth muscle defects. SM, smooth muscle; EP, epithelium. Scale
bars=50 mm (E and F); 100 mm (B and C); and 200 mm (A and D).
(TIF)
Figure S2 Follicular development in Tgfbr1 cKO mice. (A and
B) Ovaries of 3-week-old control and Tgfbr1 cKO mice containing
follicles at various developmental stages. (C and D) PMSG-
induced follicular development in control (C) and Tgfbr1 cKO (D)
mice. Arrows indicate preovulatory follicles. Scale bars=200 mm.
(TIF)
Figure S3 Corpora lutea formation in Tgfbr1 cKO mice. (A and
B) PAS staining of ovaries from PMSG-hCG treated control (A)
and Tgfbr1 cKO (B) mice. Corpora lutea formed in both control
and Tgfbr1 cKO mice after 46 h of PMSG and 20 h of hCG
treatment. (C to E) Immunohistochemical staining of 3b-HSD in
the corpora lutea of control (C) and Tgfbr1 cKO (D) mice. A
representative negative control of the Tgfbr1 cKO mouse ovary
was shown in (E). Scale bars=200 mm. CL, corpus luteum. (F)
Serum progesterone levels in gonadotropin-primed and natural
pregnant mice (n=3–4). Data are presented as mean 6 SEM.
(TIF)
Figure S4 Tgfbr1 cKO mice have defects in uterine smooth
muscle formation. (A and B) Gross uterine morphology of Tgfbr1
cKO mice at 3 weeks and 3 months of age. (C to H)
Immunostaining of ACTA2 in the uteri of control (C and F) and
Tgfbr1 cKO (D, E, G, and H) mice. Note the disrupted smooth
muscle layers in the Tgfbr1 cKO mice, and the unusual appearance
of the smooth muscle structure in the endometrium. Ut, uterus;
LM, longitudinal muscle layer; CM, circular muscle layer. Red
arrowheads point to the disorganized smooth muscle layers. Scale
bars=50 mm (F to H); 200 mm (C to E); and 5 mm (A and B).
(TIF)
Figure S5 Smooth muscle defects lead to severe disruption of
uterine structures in Tgfbr1 cKO mice. (A) Uterine abnormalities
in an 8-month-old Tgfbr1 cKO female compared to an age-
matched control mouse. Blue arrows indicate the uteri. (B to F)
Immunostaining of CNN1 in the uteri of 8-month-old control (B)
and Tgfbr1 cKO mice (C to F). CNN1 staining demonstrated
multiple structural abnormalities in the uterine smooth muscle
layers of the Tgfbr1 cKO mice. Defective smooth muscle
development leads to uterine cyst formation (arrow heads; C, D,
and E), and complete loss of normal uterine structure in the severe
cases (D and F). Scale bars=200 mm (B to F).
(TIF)
Figure S6 The uteri of Tgfbr1 cKO mice can undergo artificial
decidualization. (A and B) Gross morphology of the uteri in the
control (A) and Tgfbr1 cKO (B) mice 5 days after the decidual
stimulus. The left horns (control horns) of the uteri were
unstimulated while the right ones (decidual horns) were trauma-
tized. Note that the uteri of both control and Tgfbr1 cKO mice can
undergo artificially induced decidualization. (C) Weight ratio of
decidual horn to control horn in control (n=3) and Tgfbr1 cKO
mice (n=4). Data are presented as mean 6 SEM. (D–G)
Immunostaining of control and decidual horns of Tgfbr1 cKO
mice using CCN1. Higher magnification views of (D) and (F) are
depicted in (E) and (G), respectively. Note the disruption of smooth
muscle structure in both unstimulated and decidual horns of the
Tgfbr1 cKO mice. Scale bars=200 mm( Ea n dG ) ;4 0 0mm( Da n dF ) ,
and 10 mm (A).
(TIF)
Figure S7 Expression of target genes of miR-143/145 in Tgfbr1
cKO mice. Real-time PCR analyses using 3–4 week old oviducts
demonstrated that Elk1, Klf4, and Camk2d are expressed at
comparable levels between Tgfbr1 cKO mice and controls.
n=3–4 independent pools of oviducts. Relative mRNA levels
were normalized to Gapdh. Data are presented as mean 6 SEM.
(TIF)
Figure S8 Messenger RNA levels of genes up-regulated in Dicer1
cKO oviducts are not elevated in the oviducts of Tgfbr1 cKO mice.
Wnt5a, Wnt7a, Hoxa9, and Hoxa10 are significantly up-regulated
genes in the 3–4 week old oviducts of Dicer1 cKO mice [55]. Real-
time PCR analyses using age-matched Tgfbr1 cKO and control
oviducts did not demonstrate up-regulation of these genes in the
Tgfbr1 cKO mice. n=3–4 independent pools of oviducts. Relative
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